About me
Over the past 20 years, I have worked diligently to build and refine my skills in Drug Development, with a particular focus on the scientific elements that make up DMPK. I have continued learning and evolving the skills for scientific and organizational leadership of this discipline to add value, context and support of wider safety and chemistry of new medicines. In a CRO setting, this has enabled me to proactively support and partner with a diverse range of companies with unique molecules and modes of delivery, through in vitro investigative ADME studies, to developmental regulatory GLP studies.
As my passion for Life Sciences and Animal Welfare have continued to develop professionally, I continue to learn how to refine and adapt my approaches to the support and guidance I can provide and I remain committed to the goals of developing new molecules to improve lives and cure illnesses. In my role, I am able to focus on guiding customers on DMPK sciences and innovation, as well as help navigate and align strategies for integration of these activities in the drug development pipeline and across the multiple business units of Covance. My aims remain to build long lasting, trusting partnerships that continue to showcase Covance’s expertise, commitment to welfare, innovation and ability to bring drugs to market sooner than anyone else.
My desire for building a healthier future through successful, longstanding partnerships is built on:
🔹 Integrity
🔹 Trust
🔹 Ownership
